Article: article from journal or magazin.
Expression of Fas (APO-1/CD95) and Fas ligand (FasL) in human neuroblastoma.
Medical and pediatric oncology
Publication types: Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't - Publication Status: ppublish
BACKGROUND AND PROCEDURE: To determine the possible role of Fas/FasL system in the particularly heterogeneous behaviour of neuroblastoma (NB), we have measured the functional expression of Fas and its ligand, FasL, in primary neuroblastoma samples and cell lines by immunohistochemistry and flow cytometry. RESULTS: Our results reveal that while Fas expression is associated with low stage and more mature tumors, heterogeneous FasL expression was mostly detected in high stage tumors, with our apparent correlation to MYCN amplification. Flow cytometric analysis of cell lines demonstrated a high expression of Fas in epithelial-type, HLA class I positive cell lines, which was lost upon activation with phorbol esters. In contrast, Fas ligand was detected in only a small subset of cell lines. CONCLUSIONS: In some cell lines, cytotoxic assays revealed the ability of NB-associated Fas receptor to transduce an apoptotic signal upon triggering. The pattern of functional Fas/FasL expression in tumours and cell lines suggests that this system may be involved in the evasion of highly malignant neuroblastoma cells to host immune response.
Antigens, CD95, Apoptosis, Fas Ligand Protein, Flow Cytometry, Ganglioneuroma, Gene Amplification, Gene Expression Regulation, Neoplastic, Genes, myc, Humans, Jurkat Cells, Membrane Glycoproteins, Neoplasm Proteins, Neoplasm Staging, Neuroblastoma, Tumor Cells, Cultured
Web of science
Last modification date